SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001144204-13-062485
Filing Date
2013-11-15
Accepted
2013-11-15 17:02:42
Documents
11
Period of Report
2013-09-30

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO QUARTERLY REPORT v360785_10qa.htm 10-Q/A 1235399
2 EXHIBIT 31.1 v360785_ex31-1.htm EX-31.1 17014
3 EXHIBIT 31.2 v360785_ex31-2.htm EX-31.2 17042
4 EXHIBIT 32.1 v360785_ex32-1.htm EX-32.1 8880
5 EXHIBIT 32.2 v360785_ex32-2.htm EX-32.2 8793
  Complete submission text file 0001144204-13-062485.txt   8342646

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT mslp-20130930.xml EX-101.INS 1201108
7 XBRL TAXONOMY EXTENSION SCHEMA mslp-20130930.xsd EX-101.SCH 84145
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mslp-20130930_cal.xml EX-101.CAL 32205
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mslp-20130930_def.xml EX-101.DEF 382843
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE mslp-20130930_lab.xml EX-101.LAB 495526
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mslp-20130930_pre.xml EX-101.PRE 464282
Mailing Address 4721 IRONTON STREET DENVER CO 80239
Business Address 4721 IRONTON STREET DENVER CO 80239 (800) 210-7369
MusclePharm Corp (Filer) CIK: 0001415684 (see all company filings)

IRS No.: 770664193 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-53166 | Film No.: 131224587
SIC: 2834 Pharmaceutical Preparations